Persistent p53 protein expression is linked to increase in cancer cell death following radiation, even in tissues resistant to radiation, a new study finds. When radiation is followed by administration of an experimental anti-cancer drug that prevents p53 degradation and prolongs p53 signaling, tumors in mouse models are found to shrink significantly compared to either radiation or the drug alone.